Bioequivalence of the pharmacokinetics between tofacitinib aspartate and tofacitinib citrate in healthy subjects

Tofacitinib is an oral disease-modifying anti-rheumatic drug to selectively inhibit Janus kinases. Tofacitinib is a representative small molecule inhibitor that is used to treat many diseases including rheumatoid arthritis and various autoimmune conditions. Unlike biological agents, tofacitinib has...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Transl Clin Pharmacol
Egile Nagusiak: Shin, Wonsuk, Yang, A-Young, Yun, Hyeonji, Cho, Doo-Yeoun, Park, Kyung Hee, Shin, Hyunju, Kim, Anhye
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Society for Clinical Pharmacology and Therapeutics 2020
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7533161/
https://ncbi.nlm.nih.gov/pubmed/33062629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12793/tcp.2020.28.e13
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak